Responses
Clinical and epidemiological research
Extended report
Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial
Compose a Response to This Article
Other responses
No responses have been published for this article.